Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma
To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival. Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients a...
Gespeichert in:
| Veröffentlicht in: | Annals of surgery Jg. 261; H. 6; S. 1173 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.06.2015
|
| Schlagworte: | |
| ISSN: | 1528-1140, 1528-1140 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.
Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.
All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.
Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).
Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery. |
|---|---|
| AbstractList | To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.
Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.
All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.
Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).
Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery. To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.OBJECTIVETo evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall and disease-free survival.Identification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.BACKGROUNDIdentification of preoperative prognostic factors in liver surgery for HCC is required to better select patients and improve survival. Recent studies have shown that preoperative discrimination of patients with low skeletal muscle mass (sarcopenic patients) using computed tomography was associated with morbidity and mortality after liver and colorectal surgery. Assessment of sarcopenia could be used to evaluate patients before hepatectomy for HCC.All consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.METHODSAll consecutive patients who underwent hepatectomy for HCC in our institution, between February 2006 and September 2012, were included. Univariate and multivariate analyses evaluating prognostic factors of postoperative mortality and cancer recurrence were performed, including preoperative, surgical, and histopathological factors.Among 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).RESULTSAmong 198 patients who underwent hepatectomy for HCC, 109 patients had an available computed tomographic scan and represent the study cohort. After a median follow-up of 21.23 months, 27 patients (24.8%) died. There were 20 deaths among the 59 patients who had sarcopenia and only 7 deaths in the nonsarcopenic group. Sarcopenic patients had significantly shorter median overall survival than nonsarcopenic patients (52.3 months vs 70.3 months; P = 0.015). On multivariate analysis, sarcopenia was found to be an independent predictor of poor overall survival (hazard ratio = 3.19; P = 0.013) and disease-free survival (hazard ratio = 2.60; P = 0.001).Sarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery.CONCLUSIONSSarcopenia was found to be a strong and independent prognostic factor for mortality after hepatectomy for HCC in European patients and could be used to evaluate eligibility of patients with HCC before surgery. |
| Author | Tselikas, Lambros Pietrasz, Daniel Azoulay, Daniel Laurent, Alexis Voron, Thibault Compagnon, Philippe Salloum, Chady Luciani, Alain Pigneur, Frederic |
| Author_xml | – sequence: 1 givenname: Thibault surname: Voron fullname: Voron, Thibault organization: Departments of Digestive and Hepatobiliary Surgery †Radiology, Henri-Mondor Hospital, AP-HP, Créteil, France ‡Université Paris Est, Faculté de Médecine Créteil, Créteil, France; and §INSERM, U 955, Equipe 18, Creteil, F-94010, France – sequence: 2 givenname: Lambros surname: Tselikas fullname: Tselikas, Lambros – sequence: 3 givenname: Daniel surname: Pietrasz fullname: Pietrasz, Daniel – sequence: 4 givenname: Frederic surname: Pigneur fullname: Pigneur, Frederic – sequence: 5 givenname: Alexis surname: Laurent fullname: Laurent, Alexis – sequence: 6 givenname: Philippe surname: Compagnon fullname: Compagnon, Philippe – sequence: 7 givenname: Chady surname: Salloum fullname: Salloum, Chady – sequence: 8 givenname: Alain surname: Luciani fullname: Luciani, Alain – sequence: 9 givenname: Daniel surname: Azoulay fullname: Azoulay, Daniel |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24950264$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUE1Lw0AUXKRiP_QfiOzRS-p-ZpNjKdYWAoLVq2GTvGgkuxt3k0P_vSmt0MfAm-ENw_DmaGKdBYTuKVlSkqqnfbZakstRgl-hGZUsiSgVZHLBp2gewg8hVCRE3aApE6kkLBYz9LnXvnQd2Ebjnel02QfsLN5_O99HWNsKZ85-RT14g98gDO3xXuMtdLqHsnfmgGvnT9qV0LZDqz1ej6GNdUbfoutatwHuznuBPjbP7-ttlL2-7NarLCq54n1UAOdSaVCxTqq4ZmWh2EiBca0kE7WQsgJV0IQTpWQSS0VpVdBUkLRghdBsgR5PuZ13vwOEPjdNONbRFtwQcqpIzEZIPlofztahMFDlnW-M9of8_yfsDxXeZXI |
| CitedBy_id | crossref_primary_10_1016_j_jss_2016_12_014 crossref_primary_10_3390_life14081036 crossref_primary_10_1016_j_pan_2018_09_011 crossref_primary_10_1007_s11605_017_3580_1 crossref_primary_10_1080_17474124_2020_1757427 crossref_primary_10_1007_s10120_017_0722_9 crossref_primary_10_1016_j_nut_2021_111229 crossref_primary_10_1007_s00268_017_3909_7 crossref_primary_10_1016_j_ejso_2022_10_008 crossref_primary_10_3390_nu15051193 crossref_primary_10_1055_a_2189_6353 crossref_primary_10_1016_j_amjsurg_2018_10_039 crossref_primary_10_1007_s10147_021_01958_0 crossref_primary_10_1002_jpen_1792 crossref_primary_10_1017_S0029665115004279 crossref_primary_10_1007_s00268_015_3140_3 crossref_primary_10_1016_j_ajt_2022_11_016 crossref_primary_10_1016_j_dld_2024_12_003 crossref_primary_10_1186_s13741_016_0052_1 crossref_primary_10_1002_jcsm_12771 crossref_primary_10_1007_s00330_025_11349_y crossref_primary_10_1097_TP_0000000000001587 crossref_primary_10_1002_jcsm_12529 crossref_primary_10_1007_s00432_023_05051_z crossref_primary_10_1016_j_dld_2020_04_009 crossref_primary_10_1007_s11605_018_3695_z crossref_primary_10_1016_j_jchirv_2015_06_006 crossref_primary_10_1007_s00423_024_03274_3 crossref_primary_10_1016_j_clnu_2020_05_038 crossref_primary_10_1055_s_0043_1764281 crossref_primary_10_1016_j_surg_2022_04_022 crossref_primary_10_20960_nh_05564 crossref_primary_10_1111_jgh_15026 crossref_primary_10_1007_s11605_020_04522_9 crossref_primary_10_2147_CMAR_S275307 crossref_primary_10_1007_s11695_018_3169_0 crossref_primary_10_1245_s10434_018_6354_4 crossref_primary_10_1007_s10388_019_00670_3 crossref_primary_10_1016_j_clnu_2018_12_025 crossref_primary_10_1177_0148607115612054 crossref_primary_10_1016_j_jviscsurg_2015_08_001 crossref_primary_10_1002_jcsm_13040 crossref_primary_10_1007_s11605_016_3146_7 crossref_primary_10_1002_ygh2_412 crossref_primary_10_1016_j_clnu_2017_06_028 crossref_primary_10_1186_s12876_020_01472_z crossref_primary_10_1016_j_surge_2018_09_003 crossref_primary_10_1016_j_nut_2020_110798 crossref_primary_10_1371_journal_pone_0129742 crossref_primary_10_1002_jcsm_12995 crossref_primary_10_1111_aor_13962 crossref_primary_10_3390_diagnostics9040206 crossref_primary_10_1016_j_ejrad_2020_108889 crossref_primary_10_1097_MD_0000000000003164 crossref_primary_10_3390_jcm14176107 crossref_primary_10_3390_cancers16132315 crossref_primary_10_1016_j_surg_2020_03_005 crossref_primary_10_3389_fonc_2021_744311 crossref_primary_10_1016_S0985_0562_14_70895_7 crossref_primary_10_1016_j_clnu_2020_12_011 crossref_primary_10_3389_fnut_2023_1315097 crossref_primary_10_1007_s11605_018_3802_1 crossref_primary_10_1136_bmjopen_2019_034495 crossref_primary_10_1016_j_ejim_2022_07_002 crossref_primary_10_3390_jcm11113184 crossref_primary_10_1007_s00423_022_02541_5 crossref_primary_10_1016_j_jcrc_2017_12_027 crossref_primary_10_2147_JHC_S300680 crossref_primary_10_1007_s00423_020_01973_1 crossref_primary_10_1177_0884533616676264 crossref_primary_10_1097_JS9_0000000000001303 crossref_primary_10_1097_SLA_0000000000002679 crossref_primary_10_1097_SLA_0000000000002555 crossref_primary_10_1007_s10120_016_0683_4 crossref_primary_10_1146_annurev_nutr_082117_051723 crossref_primary_10_1111_jgh_14309 crossref_primary_10_1097_JS9_0000000000000688 crossref_primary_10_2147_JHC_S407646 crossref_primary_10_3389_fonc_2022_1007771 crossref_primary_10_1245_s10434_020_09147_5 crossref_primary_10_1590_s0004_2803_24612024_136 crossref_primary_10_1245_s10434_015_4887_3 crossref_primary_10_1038_s41598_022_27238_z crossref_primary_10_4174_astr_2025_108_6_345 crossref_primary_10_1016_j_livres_2024_03_001 crossref_primary_10_1245_s10434_015_4763_1 crossref_primary_10_1016_j_asjsur_2022_07_122 crossref_primary_10_1007_s10029_024_03174_x crossref_primary_10_3389_fnut_2022_878791 crossref_primary_10_1097_JS9_0000000000000458 crossref_primary_10_1177_00031348231160840 crossref_primary_10_2147_JHC_S418885 crossref_primary_10_1038_s41598_025_87458_x crossref_primary_10_1016_j_jvir_2019_01_005 crossref_primary_10_1016_j_ejca_2015_12_030 crossref_primary_10_1080_17474124_2021_1912591 crossref_primary_10_3748_wjg_v28_i36_5324 crossref_primary_10_1007_s00268_015_2988_6 crossref_primary_10_1016_j_archger_2021_104534 crossref_primary_10_1080_01635581_2020_1750662 crossref_primary_10_1016_j_ejso_2024_108533 crossref_primary_10_3390_jcm11071860 crossref_primary_10_1016_j_gassur_2024_03_001 crossref_primary_10_1007_s00520_019_04767_4 crossref_primary_10_3390_cells10030516 crossref_primary_10_1016_j_asjsur_2021_09_012 crossref_primary_10_1016_j_surg_2019_03_020 crossref_primary_10_1016_j_surg_2016_08_030 crossref_primary_10_1186_s12957_021_02283_6 crossref_primary_10_1186_s12885_023_11251_0 crossref_primary_10_1016_j_clnu_2020_09_016 crossref_primary_10_1002_jpen_1696 crossref_primary_10_1002_jcsm_12274 crossref_primary_10_1002_jcsm_12276 crossref_primary_10_1080_01635581_2022_2117387 crossref_primary_10_1007_s00595_020_02225_x crossref_primary_10_3892_mco_2018_1607 crossref_primary_10_2478_raon_2021_0004 crossref_primary_10_1007_s11605_019_04198_w crossref_primary_10_1016_j_arr_2022_101739 crossref_primary_10_1007_s00423_017_1589_2 crossref_primary_10_1016_j_ejso_2020_09_002 crossref_primary_10_1016_j_clnesp_2019_06_003 crossref_primary_10_1016_j_nut_2018_10_025 crossref_primary_10_2147_CMAR_S305253 crossref_primary_10_3390_cancers16061080 crossref_primary_10_1055_a_2189_8567 crossref_primary_10_1016_j_nut_2021_111232 crossref_primary_10_3389_fnut_2022_978110 crossref_primary_10_1002_cam4_4448 crossref_primary_10_1002_ags3_12547 crossref_primary_10_1016_j_surge_2018_03_001 crossref_primary_10_1186_s12957_025_03765_7 crossref_primary_10_1007_s11605_018_3878_7 crossref_primary_10_3389_fonc_2019_01561 crossref_primary_10_1016_j_clnu_2018_09_019 crossref_primary_10_1016_j_pharmthera_2018_12_003 crossref_primary_10_1002_jcsm_12258 crossref_primary_10_1093_annonc_mdx271 crossref_primary_10_1007_s00268_016_3732_6 crossref_primary_10_3748_wjg_v28_i4_432 crossref_primary_10_1016_j_nut_2021_111184 crossref_primary_10_1038_s41598_022_21443_6 crossref_primary_10_1016_j_asjsur_2020_11_001 crossref_primary_10_3390_cancers13112708 crossref_primary_10_3390_cancers14030720 crossref_primary_10_1016_j_surg_2022_09_007 crossref_primary_10_1016_j_clnu_2020_04_043 crossref_primary_10_1016_j_nut_2019_06_020 crossref_primary_10_1111_1759_7714_12855 crossref_primary_10_1016_j_urology_2024_06_030 crossref_primary_10_1007_s00423_021_02092_1 crossref_primary_10_1016_j_archger_2025_105837 crossref_primary_10_1016_j_ejso_2016_11_015 crossref_primary_10_1007_s00268_017_3999_2 crossref_primary_10_1016_j_critrevonc_2023_103965 crossref_primary_10_47717_turkjsurg_2025_6744 crossref_primary_10_1245_s10434_021_10317_2 crossref_primary_10_1007_s00595_016_1357_x crossref_primary_10_1055_a_2460_6298 crossref_primary_10_1007_s11605_015_2835_y crossref_primary_10_1634_theoncologist_2016_0066 crossref_primary_10_1016_j_nut_2022_111687 crossref_primary_10_1055_a_1589_7568 crossref_primary_10_1007_s00268_018_4861_x crossref_primary_10_1016_j_acra_2023_11_040 crossref_primary_10_1111_ans_15431 crossref_primary_10_1007_s00432_024_05975_0 crossref_primary_10_1177_00031348241241713 crossref_primary_10_1093_jjco_hyaa248 crossref_primary_10_1016_j_asjsur_2024_02_004 crossref_primary_10_1245_s10434_022_11509_0 crossref_primary_10_1002_jhbp_835 crossref_primary_10_1016_j_hpb_2018_06_1803 crossref_primary_10_1016_j_oraloncology_2017_05_012 crossref_primary_10_1007_s00464_022_09416_2 crossref_primary_10_1016_j_amjsurg_2018_11_016 crossref_primary_10_3748_wjg_v30_i13_1836 crossref_primary_10_1016_j_hpb_2020_04_004 crossref_primary_10_1155_2022_8350527 crossref_primary_10_1177_000313481908500425 crossref_primary_10_1016_j_ejso_2024_108580 crossref_primary_10_1016_j_clinre_2024_102332 crossref_primary_10_1016_j_ejso_2025_110437 crossref_primary_10_1016_j_jhep_2018_06_024 crossref_primary_10_1017_S002966511500419X crossref_primary_10_1007_s13304_021_01175_4 crossref_primary_10_3389_fonc_2020_596691 crossref_primary_10_1186_s12876_025_04176_4 crossref_primary_10_1007_s00261_024_04439_w crossref_primary_10_1097_TP_0000000000001413 crossref_primary_10_1159_000531797 crossref_primary_10_1016_j_hpb_2016_11_009 crossref_primary_10_1245_s10434_017_6269_5 crossref_primary_10_1016_j_gassur_2024_09_002 crossref_primary_10_1007_s00595_021_02346_x crossref_primary_10_1002_jso_23976 crossref_primary_10_1016_j_ijsu_2022_106842 crossref_primary_10_1016_j_arr_2023_102057 crossref_primary_10_1111_ggi_13320 crossref_primary_10_1186_s40001_022_00760_6 crossref_primary_10_1007_s00268_017_4255_5 crossref_primary_10_1136_bmjopen_2023_083228 crossref_primary_10_1245_s10434_020_09143_9 crossref_primary_10_3389_fnut_2024_1292834 crossref_primary_10_1016_j_jgo_2018_01_003 crossref_primary_10_3390_diagnostics13050968 crossref_primary_10_1016_j_hpb_2023_08_012 crossref_primary_10_1007_s00268_016_3504_3 crossref_primary_10_1017_S0029665120007855 crossref_primary_10_1016_j_surg_2015_08_047 crossref_primary_10_1016_j_ejso_2024_108246 crossref_primary_10_1016_j_transproceed_2023_12_008 crossref_primary_10_1111_cts_12940 crossref_primary_10_1055_a_2026_1240 crossref_primary_10_1007_s00432_016_2230_4 crossref_primary_10_1002_cam4_6030 crossref_primary_10_1245_s10434_017_6020_2 crossref_primary_10_1159_000493586 crossref_primary_10_1016_j_ejso_2016_09_006 crossref_primary_10_3892_ol_2023_13869 crossref_primary_10_1007_s00535_020_01711_w crossref_primary_10_1016_j_surge_2017_06_001 crossref_primary_10_1016_j_clcc_2022_10_001 crossref_primary_10_1017_S0029665118000046 crossref_primary_10_1111_codi_14558 crossref_primary_10_1016_j_ejso_2018_09_030 crossref_primary_10_1097_MD_0000000000023363 crossref_primary_10_1093_jjco_hyaa218 crossref_primary_10_1016_j_clnesp_2022_04_009 crossref_primary_10_1097_SLA_0000000000001048 crossref_primary_10_3390_cancers14010261 crossref_primary_10_3390_jcm8101672 crossref_primary_10_1007_s00464_020_08041_1 crossref_primary_10_1245_s10434_017_6077_y crossref_primary_10_1093_ibd_izy212 crossref_primary_10_1002_jpen_1171 crossref_primary_10_1016_j_dld_2021_10_010 crossref_primary_10_1186_s12885_022_09823_7 crossref_primary_10_3389_fnut_2023_1040297 crossref_primary_10_1159_000502125 crossref_primary_10_3390_cancers15225391 crossref_primary_10_3389_fnut_2023_1233973 crossref_primary_10_4240_wjgs_v16_i6_1857 crossref_primary_10_1002_jcsm_12431 crossref_primary_10_1080_01635581_2022_2159046 crossref_primary_10_1093_jjco_hyac087 crossref_primary_10_3390_gidisord3010006 crossref_primary_10_3350_cmh_2020_0192 crossref_primary_10_1002_jcsm_13759 crossref_primary_10_1631_jzus_B2300363 crossref_primary_10_1016_j_jss_2016_12_002 crossref_primary_10_1093_ndt_gfy108 crossref_primary_10_1111_hepr_13667 crossref_primary_10_1308_rcsann_2021_0082 crossref_primary_10_14235_bas_galenos_2022_87894 crossref_primary_10_1002_jhbp_236 crossref_primary_10_1016_j_clnesp_2022_10_003 crossref_primary_10_1245_s10434_019_07188_z crossref_primary_10_1016_j_jvs_2017_06_085 crossref_primary_10_1016_j_clnu_2017_07_010 crossref_primary_10_1245_s10434_014_4281_6 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/SLA.0000000000000743 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1528-1140 |
| ExternalDocumentID | 24950264 |
| Genre | Journal Article |
| GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 1J1 23M 2WC 354 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAEJM AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHJKT AHOMT AHQNM AHQVU AHRYX AHVBC AI. AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AZFZN BAWUL BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DUNZO E.X E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FEDTE FL- FW0 GNXGY GQDEL H0~ HLJTE HVGLF HZ~ IH2 IKREB IKYAY IN~ IPNFZ J5H JF7 JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A NPM N~7 N~B N~M O9- OAG OAH OBH OCB OCUKA ODA ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RIG RLZ RPM RXW S4R S4S T8P TAF TEORI TR2 TSPGW UQX V2I VH1 VVN W3M WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC ZFV ZGI ZXP ZY1 ZZMQN ~H1 7X8 ADKSD ADSXY |
| ID | FETCH-LOGICAL-c373t-be3357ae76a8d6f2cb726a8e23a7524f455de7b1830775865711db19409b2b4a2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 326 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000369611600049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-1140 |
| IngestDate | Mon Sep 08 13:30:43 EDT 2025 Mon Jul 21 05:27:51 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c373t-be3357ae76a8d6f2cb726a8e23a7524f455de7b1830775865711db19409b2b4a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 24950264 |
| PQID | 1706206253 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1706206253 pubmed_primary_24950264 |
| PublicationCentury | 2000 |
| PublicationDate | 2015-Jun 20150601 |
| PublicationDateYYYYMMDD | 2015-06-01 |
| PublicationDate_xml | – month: 06 year: 2015 text: 2015-Jun |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annals of surgery |
| PublicationTitleAlternate | Ann Surg |
| PublicationYear | 2015 |
| SSID | ssj0014807 |
| Score | 2.6090262 |
| Snippet | To evaluate the prevalence of sarcopenia among European patients with resectable hepatocellular carcinoma (HCC) and to assess its prognostic impact on overall... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1173 |
| SubjectTerms | Aged Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - surgery Comorbidity Disease-Free Survival Female Hepatectomy - mortality Humans Liver Neoplasms - epidemiology Liver Neoplasms - surgery Male Middle Aged Neoplasm Recurrence, Local - epidemiology Patient Selection Prevalence Prognosis Retrospective Studies Sarcopenia - diagnostic imaging Sarcopenia - epidemiology Survival Analysis Tomography, X-Ray Computed Treatment Outcome |
| Title | Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24950264 https://www.proquest.com/docview/1706206253 |
| Volume | 261 |
| WOSCitedRecordID | wos000369611600049&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qfPDFC97mjQi-hq1NsqRPMoZjwhzDKezJ0qSJDlwz7Sb47z3phT0JgqWUlhIIp6fnfOeO0I2WGhS3DUgAYJ6w1LSJUpEhOlAqkMpGXBaFwkMxGsnpNBpXDre8SqusZWIhqFOnvY-85du8hHByerv4IH5qlI-uViM0NlGDApTxKV1iuo4iVOXSoKLAUgJLoi6di0RrMuyWrQvrQ_i6nd9AZqFs-nv_3eY-2q1gJu6WfHGANkx2iF4mwNV-XNYswfdFdWSOXYYnbwDBCU6yFA9d9kq8sMaPJl-9-_cWD0Bj-VCDm39jgLjls_Mef5_Cint-GlHm5skReu7fPfUGpJqvQDQVdEmUoZSLxIhOItOODbUSIdyakCaCh8wyzlMj4JNR3ydPdrgIglQFEZiEKlQsCY_RVuYyc4pwyq2ERVIDyZlkNpJK2LayNtVStZloouuaXDHwr99ikhm3yuM1wZropKR5vCgbbcR-LjbYiOzsD6vP0Q5gGV5mcV2ghoW_11yibf21nOWfVwVjwHU0fvgBjAbB-g |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenia+Impacts+on+Short-+and+Long-term+Results+of+Hepatectomy+for+Hepatocellular+Carcinoma&rft.jtitle=Annals+of+surgery&rft.au=Voron%2C+Thibault&rft.au=Tselikas%2C+Lambros&rft.au=Pietrasz%2C+Daniel&rft.au=Pigneur%2C+Frederic&rft.date=2015-06-01&rft.eissn=1528-1140&rft.volume=261&rft.issue=6&rft.spage=1173&rft_id=info:doi/10.1097%2FSLA.0000000000000743&rft_id=info%3Apmid%2F24950264&rft_id=info%3Apmid%2F24950264&rft.externalDocID=24950264 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-1140&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-1140&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-1140&client=summon |